Circular of the General Administration of the people's Republic of China on the issuance of Biostatistics guidelines for clinical trials of drugs (No. 93, 2016)
-
Last Update: 2016-06-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: CFDA 2016-06-06 in order to strengthen the guidance and specification of Biostatistics in clinical trials of drugs, the State Food and drug administration has organized and formulated the biostatistics guidelines for clinical trials of drugs, which are hereby promulgated and shall be implemented as of the date of promulgation of this circular The biostatistics technical guidelines for clinical trials of chemical drugs and biological products issued by the former State Food and Drug Administration in the notice on Issuing 16 technical guidelines for chemical drug stability research (gsyjz [2005] No 106) shall be abolished Notice is hereby given Annex: biostatistics guidelines for clinical trials of drugs annex.docx to Circular No 93 of food and Drug Administration of the people's Republic of China on June 1, 2016
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.